Philippines President Orders Prices Of Five ‘Essential Drugs' Cut In Half
This article was originally published in PharmAsia News
Executive Summary
The Philippines president ordered a cap on the prices of five types of drugs deemed essential, with the effect of cutting the prices in half as of Aug. 15. The action had been recommended after drug makers failed to lower the prices of the five drugs on their own while agreeing to cut them on another 16 on the government's list. The industry also volunteered to cut prices of some drugs not on the list and said the order by President Gloria Macapagal Arroyo was not the best way to get essential drugs to The Philippines' poor. (Click here for moreYou may also be interested in...
Did Sarepta Need To Tell Investors About Its Vyondys 53 Dispute Resolution Request?
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Horizon's Teprotumumab Breezes Through US FDA Adcom, But Safety Questions Remain
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.
Need a specific report? 1000+ reports available
Buy Reports